Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
Ad hoc announcement pursuant to Art. 53 LR
Covered in this story
Call it yourself
No calls on $NOVN.SW yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Novartis →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.